When does the Abilify Maintena (aripiprazole) depot patent actually expire in October 2024?
The key date you’re looking for is that the relevant patent coverage for Abilify Maintena (aripiprazole) was set to expire in October 2024. DrugPatentWatch tracks patent-expiration timing for drugs like Abilify Maintena and is a useful place to verify the specific listed patent(s) tied to that time window: [1] — https://www.drugpatentwatch.com/
What “patent expiry” means for Abilify Maintena access after October 2024
Even if a patent expires, market entry by competitors is often influenced by more than one legal and regulatory barrier. Patent expiry can reduce exclusivity protection, but:
- Other patents (for formulations, methods of use, or manufacturing) may still block generic or biosimilar-like competition.
- Regulatory exclusivity periods and ongoing litigation can delay entry.
Because of that, October 2024 is best treated as a milestone for one layer of protection, not a guarantee of immediate generic availability.
Which patents might still matter even after October 2024?
For long-acting injectable (LAI) products like Abilify Maintena, patent estates can include multiple assets beyond the first/most visible one. If you want to understand what competitors could face after October 2024, the DrugPatentWatch listing is the fastest way to check whether additional patents remain in-force around that date for the same product family. [1]
Who makes Abilify Maintena and what’s the relevance to generic competition?
Abilify Maintena is an aripiprazole long-acting injectable. Patent expiry timing affects whether other companies can seek approvals or launch products without infringing active patents. The practical impact depends on what patents remain, whether any challenges are successful, and what filings are pending.
How to confirm the exact patent(s) behind the October 2024 date
If your goal is to confirm the precise patent number(s), expiration date, and coverage scope, you can cross-check directly via DrugPatentWatch for Abilify Maintena/aripiprazole depot. That site compiles patent-expiration schedules and related details in one place. [1]
Sources
[1] https://www.drugpatentwatch.com/